Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.15B |
| 3 |
GE HealthCare
GEHC
|
+$552M |
| 4 |
Danaher
DHR
|
+$447M |
| 5 |
Strategy Inc
MSTR
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$989M |
| 2 |
Boeing
BA
|
+$893M |
| 3 |
Bank of America
BAC
|
+$753M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$750M |
| 5 |
Coca-Cola
KO
|
+$638M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.24% |
| 2 | Technology | 2.87% |
| 3 | Financials | 2.43% |
| 4 | Consumer Discretionary | 2.22% |
| 5 | Industrials | 1.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAGE
11476
PUT
Niagen Bioscience
NAGE
$239M
| $97.3K | ﹤0.01% |
14,100
+8,300
| +143% | +$52.2K |
|
11477
CALL
Maravai LifeSciences
MRVI
$849M
| $97.2K | ﹤0.01% |
44,000
-16,500
| -27% | -$65.2K |
|
11478
Mega Matrix
MPU
$14.3M
| $97.2K | ﹤0.01% |
148,849
+123,094
| +478% | +$115K |
|
11479
PUT
Texas Capital Bancshares
TCBI
$4.39B
| $97.1K | ﹤0.01% |
1,300
-19,200
| -94% | -$1.49M |
|
11480
CALL
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $97K | ﹤0.01% |
2,400
+1,100
| +85% | +$45.4K |
|
11481
Ring Energy
REI
$357M
| $96.9K | ﹤0.01% |
84,243
-1,568,063
| -95% | -$2.05M |
|
11482
CALL
Unisys
UIS
$209M
| $96.8K | ﹤0.01% |
21,100
-45,700
| -68% | -$255K |
|
11483
CALL
Puma Biotechnology
PBYI
$456M
| $96.8K | ﹤0.01% |
32,700
+14,800
| +83% | +$46.3K |
|
11484
CALL
Transcat
TRNS
$877M
| $96.8K | ﹤0.01% |
1,300
+600
| +86% | +$50.3K |
|
11485
PUT
Mayville Engineering Co
MEC
$614M
| $96.7K | ﹤0.01% |
7,200
+4,100
| +132% | +$61.7K |
|
11486
CVD Equipment Corp
CVV
$56.1M
| $96.7K | ﹤0.01% |
31,491
+6,233
| +25% | +$21.4K |
|
11487
WidePoint Corp
WYY
$94.5M
| $96.6K | ﹤0.01% |
29,023
-421
| -1% | -$1.6K |
|
11488
PUT
Seanergy Maritime Holdings
SHIP
$363M
| $96.6K | ﹤0.01% |
15,100
-8,500
| -36% | -$59.4K |
|
11489
CALL
Simply Good Foods
SMPL
$1B
| $96.6K | ﹤0.01% |
2,800
-16,700
| -86% | -$604K |
|
11490
PUT
Atlantic Union Bankshares
AUB
$6.12B
| $96.5K | ﹤0.01% |
3,100
+2,400
| +343% | +$85.3K |
|
11491
PUT
State Street SPDR S&P Pharmaceuticals ETF
XPH
$518M
| $96.4K | ﹤0.01% |
2,200
-14,100
| -87% | -$622K |
|
11492
PUT
Runway Growth Finance
RWAY
$290M
| $96.3K | ﹤0.01% |
9,300
-16,500
| -64% | -$185K |
|
11493
CALL
Talos Energy
TALO
$2.63B
| $96.2K | ﹤0.01% |
9,900
-89,300
| -90% | -$846K |
|
11494
PUT
Merchants Bancorp
MBIN
$2.52B
| $96.2K | ﹤0.01% |
2,600
-3,200
| -55% | -$126K |
|
|
ACTU
11495
Actuate Therapeutics
ACTU
$24.2M
| $96K | ﹤0.01% |
+14,185
| New | +$114K |
|
11496
RAVE Restaurant Group
RAVE
$43.2M
| $96K | ﹤0.01% |
34,891
-6,189
| -15% | -$16.5K |
|
|
PML
11497
PIMCO Municipal Income Fund II
PML
$493M
| $95.9K | ﹤0.01% |
11,844
-2,289
| -16% | -$19.1K |
|
11498
First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF
FTRI
$130M
| $95.9K | ﹤0.01% |
7,244
-29,451
| -80% | -$374K |
|
11499
PUT
Fidus Investment
FDUS
$744M
| $95.8K | ﹤0.01% |
4,700
-6,500
| -58% | -$143K |
|
|
SBT
11500
CALL
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $95.8K | ﹤0.01% |
19,800
+5,800
| +41% | +$27.4K |
|
Similar funds
Ken Griffin's Q1 2025 Portfolio in Review
As of Q1 2025, Ken Griffin held 16,069 positions worth $527B, down 8.7% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin's Q1 2025 filing shows 1,671 new, 6,327 increased, 6,228 reduced and 1,709 closed positions. Its largest new stake was CMS Energy: 1,417,315 shares worth $106M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $989M.
By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 3.1% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q1 2025 buy was CMS Energy: 1,417,315 shares worth $106M.
- Ken Griffin added most to Charles Schwab in Q1 2025, an estimated $1.44B increase.
- Ken Griffin's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $989M.
- Ken Griffin fully exited Walmart Inc in Q1 2025, selling an estimated $462M.
- Ken Griffin's ten largest holdings make up 32% of its $527B portfolio in Q1 2025.
- Ken Griffin opened 1,671 new positions and closed 1,709 in Q1 2025.
- Ken Griffin's portfolio value fell 8.7% quarter-over-quarter to $527B.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.